The Relationship Between Sarcopenia, Cognitive Impairment, and Cerebral White Matter Hyperintensity in the Elderly

References

• Sui SX, Williams LJ, Holloway-Kew KL, et al. Skeletal muscle health and cognitive function: a narrative review. Int J Mol Sci. 2020;22(1):255. doi:10.3390/ijms22010255
   PubMed Web of Science ®Google Scholar
• Chen X, Han P, Yu X, et al. Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling older adults. J Affect Disord. 2021;286:71–77. doi:10.1016/j.jad.2021.02.067
   PubMed Web of Science ®Google Scholar
• Pieruccini-Faria F, Sarquis-Adamson Y, Anton-Rodrigo I, et al. Mapping associations between gait decline and fall risk in mild cognitive impairment. J Am Geriatr Soc. 2020;68(3):576–584. doi:10.1111/jgs.16265
   PubMed Web of Science ®Google Scholar
• McGrath R, Vincent BM, Hackney KJ, Robinson-Lane SG, Downer B, Clark BC. The longitudinal associations of handgrip strength and cognitive function in aging Americans. J Am Med Dir Assoc. 2020;21(5):634–639.e1. doi:10.1016/j.jamda.2019.08.032
   PubMed Web of Science ®Google Scholar
• Verghese J, Wang C, Lipton RB, Holtzer R. Motoric cognitive risk syndrome and the risk of dementia. J Gerontol a Biol Sci Med Sci. 2013;68(4):412–418. doi:10.1093/gerona/gls191
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• van de Schraaf SAJ, Rhodius-Meester HFM, Aben L, et al. Slowing: a vascular geriatric syndrome? J Am Med Dir Assoc. 2022;23(1):47–53.e2. doi:10.1016/j.jamda.2021.07.031
   PubMed Web of Science ®Google Scholar
• Duchowny KA, Ackley SF, Brenowitz WD, et al. Associations between handgrip strength and dementia risk, cognition, and neuroimaging outcomes in the UK biobank cohort study. JAMA Netw Open. 2022;5(6):e2218314. doi:10.1001/jamanetworkopen.2022.18314
   PubMed Web of Science ®Google Scholar
• Hu HY, Ou YN, Shen XN, et al. White matter hyperintensities and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2021;120:16–27. doi:10.1016/j.neubiorev.2020.11.007
   PubMed Web of Science ®Google Scholar
• Hilal S, Liu S, Wong TY, et al. White matter network damage mediates association between cerebrovascular disease and cognition. J Cereb Blood Flow Metab. 2021;41(8):1858–1872. doi:10.1177/0271678X21990980
   PubMed Web of Science ®Google Scholar
• Habes M, Pomponio R, Shou H, et al. The brain chart of aging: machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimers Dement. 2021;17(1):89–102. doi:10.1002/alz.12178
   PubMed Web of Science ®Google Scholar
• Tian Q, Studenski SA, An Y, et al. Association of combined slow gait and low activity fragmentation with later onset of cognitive impairment. JAMA Netw Open. 2021;4(11):e2135168. doi:10.1001/jamanetworkopen.2021.35168
   PubMed Web of Science ®Google Scholar
• Jin YL, Xu L, Jiang CQ, et al. Association of hand grip strength with mild cognitive impairment in middle-aged and older people in Guangzhou biobank cohort study. Int J Environ Res Public Health. 2022;19(11):6464. doi:10.3390/ijerph19116464
   PubMed Web of Science ®Google Scholar
• Ishii H, Makizako H, Doi T, Tsutsumimoto K, Shimada H. Associations of skeletal muscle mass, lower-extremity functioning, and cognitive impairment in community-dwelling older people in Japan. J Nutr Health Aging. 2019;23(1):35–41. doi:10.1007/s12603-018-1110-9
   PubMed Web of Science ®Google Scholar
• Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ, Cano CA. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res. 2017;29(2):265–272. doi:10.1007/s40520-016-0561-2
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356. doi:10.2214/ajr.149.2.351
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Lu J, Li D, Li F, et al. Montreal cognitive assessment detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol. 2011;24(4):184–190. doi:10.1177/0891988711422528
   PubMed Web of Science ®Google Scholar
• Peng TC, Chen WL, Wu LW, et al. Sarcopenia and cognitive impairment: a systematic review and meta-analysis. Clin Nutr. 2020;39(9):2695–2701. doi:10.1016/j.clnu.2019.12.014
   PubMed Web of Science ®Google Scholar
• Veronese N, Stubbs B, Trevisan C, et al. What physical performance measures predict incident cognitive decline among intact older adults? A 4.4 year follow up study. Exp Gerontol. 2016;81:110–118. doi:10.1016/j.exger.2016.05.008
   PubMed Web of Science ®Google Scholar
• Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS. Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021;69(7):1826–1835. doi:10.1111/jgs.17206
   PubMed Web of Science ®Google Scholar
• Salinas-Rodríguez A, Palazuelos-González R, Rivera-Almaraz A, Manrique-Espinoza B. Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults. J Cachexia Sarcopenia Muscle. 2021;12(6):1848–1859. doi:10.1002/jcsm.12787
   PubMed Web of Science ®Google Scholar
• Kim M, Won CW. Sarcopenia is associated with cognitive impairment mainly due to slow gait speed: results from the Korean Frailty and Aging Cohort Study (KFACS). Int J Environ Res Public Health. 2019;16(9):1491. doi:10.3390/ijerph16091491
   PubMed Web of Science ®Google Scholar
• Yoshimura Y, Bise T, Shimazu S, et al. Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia: a randomized controlled trial. Nutrition. 2019;58:1–6. doi:10.1016/j.nut.2018.05.028
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Yoshimura Y, Shimazu S, et al. Effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation: a multicenter randomized controlled trial. Geriatr Gerontol Int. 2019;19(1):12–17. doi:10.1111/ggi.13547
   PubMed Web of Science ®Google Scholar
• Dominguez LJ, Veronese N, Vernuccio L, et al. Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia. Nutrients. 2021;13(11):4080. doi:10.3390/nu13114080
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Solmi M, Firth J, et al. The impact of pharmacologic and nonpharmacologic interventions to improve physical health outcomes in people with dementia: a meta-review of meta-analyses of randomized controlled trials. J Am Med Dir Assoc. 2020;21(10):1410–1414. doi:10.1016/j.jamda.2020.01.010
   PubMed Web of Science ®Google Scholar